Intapp, Inc.: Form 10-Q for the period ended Mar 31, 2026
Filed with the SEC on May 5, 2026 and accepted by EDGAR at May 5, 2026, 16:18 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2026-03-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2026-01-01 to 2026-03-31 | $146.0m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 9 months2025-07-01 to 2026-03-31 | $425.3m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2026-01-01 to 2026-03-31 | $35.5m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 9 months2025-07-01 to 2026-03-31 | $105.8m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months2026-01-01 to 2026-03-31 | $110.5m | us-gaap:GrossProfit |
| Gross profit | 9 months2025-07-01 to 2026-03-31 | $319.5m | us-gaap:GrossProfit |
| Research and development | 3 months2026-01-01 to 2026-03-31 | $44.1m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 9 months2025-07-01 to 2026-03-31 | $124.4m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months2026-01-01 to 2026-03-31 | −$14.2m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2025-07-01 to 2026-03-31 | −$35.9m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months2026-01-01 to 2026-03-31 | $1.1m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2025-07-01 to 2026-03-31 | $2.7m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2026-01-01 to 2026-03-31 | −$15.5m | us-gaap:NetIncomeLoss |
| Net income | 9 months2025-07-01 to 2026-03-31 | −$35.8m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2026-01-01 to 2026-03-31 | −$0.20 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2025-07-01 to 2026-03-31 | −$0.44 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2026-01-01 to 2026-03-31 | −$0.20 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2025-07-01 to 2026-03-31 | −$0.44 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2026-01-01 to 2026-03-31 | 78,872,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2025-07-01 to 2026-03-31 | 80,613,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2025-07-01 to 2026-03-31 | $100.6m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months2025-07-01 to 2026-03-31 | $1.8m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Share repurchases | 9 months2025-07-01 to 2026-03-31 | $250.1m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2026-03-31 | $146.8m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2026-03-31 | $275.7m | us-gaap:AssetsCurrent |
| Total assets | At period end2026-03-31 | $709.1m | us-gaap:Assets |
| Current liabilities | At period end2026-03-31 | $360.5m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2026-03-31 | $388.9m | us-gaap:Liabilities |
| Shareholders' equity | At period end2026-03-31 | $320.2m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001565687-26-000037. Last ingested by Listed: Oct 27, 2026, 16:42 ET. Listed shows no prices and gives no investment advice.